ornithylaspartate has been researched along with glutamic acid in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Butterworth, RF; Kircheis, G; Michalak, A; Pannunzio, P; Quack, G; Rose, C; Therrien, G | 1 |
| Butterworth, RF; Kircheis, G; Michalak, A; Quack, G; Rao, KV; Rose, C | 1 |
| Delcker, A; Mihm, U; Pilatus, U; Raab, P; Rusch, O; Turowski, B; Zanella, FE; Zeuzem, S | 1 |
| Gregor, M; Hass, HG; Hösl, F; Kaiser, S; Nägele, T; Seeger, U | 1 |
| Kircheis, G; Lüth, S | 1 |
1 review(s) available for ornithylaspartate and glutamic acid
| Article | Year |
|---|---|
Pharmacokinetic and Pharmacodynamic Properties of L-Ornithine L-Aspartate (LOLA) in Hepatic Encephalopathy.
Topics: Ammonia; Animals; Brain; Dipeptides; Glutamic Acid; Glutamine; Hepatic Encephalopathy; Humans; Liver; Liver Cirrhosis; Muscles; Rats; Signal Transduction | 2019 |
4 other study(ies) available for ornithylaspartate and glutamic acid
| Article | Year |
|---|---|
L-ornithine-L-aspartate in experimental portal-systemic encephalopathy: therapeutic efficacy and mechanism of action.
Topics: Ammonia; Animals; Dipeptides; Glutamic Acid; Hepatic Encephalopathy; Male; Portacaval Shunt, Surgical; Rats; Rats, Sprague-Dawley; Urea | 1998 |
L-ornithine-L-aspartate lowers plasma and cerebrospinal fluid ammonia and prevents brain edema in rats with acute liver failure.
Topics: Ammonia; Animals; Brain Edema; Dipeptides; Glutamic Acid; Liver Failure, Acute; Male; Rats; Rats, Sprague-Dawley | 1999 |
Proton MR spectroscopy of neurometabolites in hepatic encephalopathy during L-ornithine-L-aspartate treatment--results of a pilot study.
Topics: Aged; Brain; Creatine; Dipeptides; Female; Glutamic Acid; Glutamine; Hepatic Encephalopathy; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Pilot Projects; Predictive Value of Tests; Reproducibility of Results; Treatment Outcome | 2002 |
[Detection of subclinical and overt hepatic encephalopathy and treatment control after L-ornithine-L-aspartate medication by magnetic resonance spectroscopy ((1)H-MRS)].
Topics: Adult; Ammonia; Brain; Choline; Combined Modality Therapy; Creatinine; Diet, Protein-Restricted; Dipeptides; Energy Metabolism; Female; Follow-Up Studies; Glutamic Acid; Glutamine; Hepatic Encephalopathy; Humans; Infusions, Intravenous; Inositol; Liver Cirrhosis; Magnetic Resonance Spectroscopy; Male; Middle Aged; Neuropsychological Tests; Pilot Projects; Prospective Studies; Reference Values; Statistics as Topic | 2005 |